Hans Bøtker

One-step anatomic and function testing by cardiac CT versus second-line functional testing in symptomatic patients with coronary artery stenosis: head-to-head comparison of CT-derived fractional flow reserve and myocardial perfusion imaging

Westra J, Li Z, Rasmussen L, Winther S, Li G, Nissen L, Petersen S, Ejlersen J, Isaksen C, Gormsen L, Urbonaviciene G, Eftekhari A, Weng T, Qu X, Bøtker H, Christiansen E, Holm N, Bøttcher M, Tu S

September 20, 2021 | 10.4244/EIJ-D-20-00905

Ten-year outcomes from a randomised comparison of zotarolimus-eluting and sirolimus-eluting stents: the SORT OUT III study

Pareek M, Madsen M, Warnakula Olesen K, Jensen L, Christiansen E, Dalby Kristensen S, Lassen J, Thuesen L, Bøtker H, Maeng M

December 6, 2019 | 10.4244/EIJ-D-19-00503

Plaque burden influences accurate classification of fibrous cap atheroma by in vivo optical coherence tomography in a porcine model of advanced coronary atherosclerosis

Poulsen CB, Pedrigi RM, Pareek N, Kilic I, Holm N, Bentzon JF, Bøtker H, Falk E, Krams R, de Silva R

November 20, 2018 | 10.4244/EIJ-D-17-01028

One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis

Hansen KN, Bendix K, Antonsen L, Veien K, Maeng M, Junker A, Christiansen E, Kahlert J, Terkelsen CJ, Christensen LB, Fallesen C, Bøtker H, Jensen L

October 19, 2018 | 10.4244/EIJ-D-17-00800

Two-year outcome after biodegradable polymer sirolimus- and biolimus-eluting coronary stents (from the randomised SORT OUT VII trial)

Jensen L, Maeng M, Raungaard B, Hansen K, Kahlert J, Jensen SE, Hansen H, Lassen J, Bøtker H, Christiansen E

January 19, 2018 | 10.4244/EIJ-D-17-00731

Final five-year outcomes after implantation of biodegradable polymer-coated biolimus-eluting stents versus durable polymer-coated sirolimus-eluting stents

Jakobsen L, Christiansen E, Maeng M, Hansen K, Kristensen SD, Bøtker H, Terkelsen CJ, Jensen SE, Raungaard B, Madsen M, Lassen J, Jensen L

December 20, 2017 | 10.4244/EIJ-D-17-00434

A post hoc analysis of long-term prognosis after exenatide treatment in patients with ST-segment elevation myocardial infarction

Kyhl K, Lønborg J, Vejlstrup N, Kelbæk H, Helqvist S, Holmvang L, Jørgensen E, Saunamäki K, Bøtker H, Clemmensen P, Køber L, Treiman M, Engstrøm T

July 20, 2016 | 10.4244/EIJV12I4A78

Feasibility and early safety of hybrid coronary revascularisation combining off-pump coronary surgery through J-hemisternotomy with percutaneous coronary intervention

Modrau I, Nielsen P, Bøtker H, Christiansen E, Krusell L, Kaltoft A, Terkelsen CJ, Kristensen SD, Lassen J, Thuesen L, Maeng M

February 20, 2015 | 10.4244/EIJV10I10A195

ST peak during percutaneous coronary intervention serves as an early prognostic predictor in patients with ST-segment elevation myocardial infarction

Lønborg J, Kelbæk H, Engstrøm T, Helqvist S, Kløvgaard L, Holmvang L, Vejlstrup N, Jørgensen E, Saunamäki K, Dridi N, Kaltoft A, Bøtker H, Clemmensen P, Terkelsen CJ

August 19, 2014 | 10.4244/EIJV10I4A80

Randomised comparison of manual compression and FemoSeal™ vascular closure device for closure after femoral artery access coronary angiography: the CLOSure dEvices Used in everyday Practice (CLOSE-UP) study

Holm N, Sindberg B, Schou M, Maeng M, Kaltoft A, Bottcher M, Krusell L, Hjort J, Thuesen L, Terkelsen CJ, Christiansen E, Bøtker H, Kristensen SD, Lassen J

June 20, 2014 | 10.4244/EIJV10I2A31

Outcomes after revascularisation with everolimus- and sirolimus-eluting stents in patients with acute coronary syndromes and stable angina pectoris: a substudy of the SORT OUT IV trial

Antonsen L, Thayssen P, Hansen H, Maeng M, Tilsted H, Bøtker H, Ravkilde J, Madsen M, Sørensen H, Thuesen L, Lassen J, Jensen L

June 20, 2014 | 10.4244/EIJV10I2A35

Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study

Ruiz-Garc J, Lerman A, Weisz G, Maehara A, Mintz G, Fahy M, Xu K, Lansky A, Cristea E, Farah T, Teles R, Bøtker H, Templin B, Zhang Z, De Bruyne B, Serruys P, Stone G

December 28, 2012 | 10.4244/EIJV8I8A142

Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Jensen L, Maeng M, Thayssen P, Villadsen A, Krusell L, Bøtker H, Pedersen K, Aaroe J, Christiansen E, Vesterlund T, Hansen K, Ravkilde J, Tilsted H, Lassen J, Thuesen L

July 29, 2011 | 10.4244/EIJV7I3A56

A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial

Kastrup J, Jørgensen E, Fuchs S, Nikol S, Bøtker H, Gyöngyösi M, Glogar D, Kornowski R

February 21, 2011

Familial hypercholesterolaemic downsized pig with human-like coronary atherosclerosis: a model for preclinical studies

Thim T, Hagensen M, Drouet L, Sollier C, Bonneau M, Granada J, Nielsen L, Paaske W, Bøtker H, Falk E

June 30, 2010 | 10.4244/EIJV6I2A42

Efficiency and safety of the sirolimus eluting stent in complex coronary artery lesions after cessation of dual antiplatelet therapy: fifteen months clinical outcome of the randomised Stenting Coronary Arteries in Non-stress/benestent Disease (SCANDSTENT) trial

Helqvist S, Kelbæk H, Thuesen L, Kløvgaard L, Krusell L, Jørgensen E, Bøtker H, Jensen G, Lassen J, Thayssen P, Galloe A, Saunamäki K

November 20, 2007

Impact of drug eluting stents on target vessel revascularization. A report from the Western Denmark heart registry from 2000 to 2004.

Okkels Jensen L, Maeng M, Thayssen P, Lassen J, Bøtker H, Rasmussen K, Thuesen L

February 20, 2006

Outcome of unprotected left main percutaneous coronary intervention in surgical low-risk, surgical high-risk, and acute myocardial infarction patients

Christiansen E, Lassen J, Andersen H, Romer Krusell L, Dalby Kristensen S, Bøtker H, Thuesen L

February 20, 2006

Randomized comparison of deliverability and in-hospital complications in implantation of BxSonic®, Express® and Flexmaster® coronary stents

Thuesen L, Galloe A, Thayssen P, Rasmussen K, Kelbæk H, Lassen J, Hansen P, Pedersen K, Ravkilde J, Helqvist S, Abildgaard U, Andersen H, Bøtker H, Kristensen SD, Hjort J, Romer Krusell L

November 20, 2005

In-laboratory femoral sheath removal after heparin reversal by protamine after percutaneous coronary intervention

Thuesen L, Rud Andersen H, Bøtker H, Kristensen SD, Romer Krusell L, Lassen J

May 20, 2005

Hans Bøtker

Latest news